Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia
Public ClinicalTrials.gov record NCT02458287. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12 Week, Phase 3, Double-blind, Randomized, Placebo-controlled, Parallel Group Study To Assess The Efficacy, Safety, Tolerability And Actual Use Of Bococizumab And An Autoinjector (Pre-filled Pen) In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a multicenter, randomized study in subjects with high cholesterol receiving statins to assess the efficacy to lower LDL-C, the safety, tolerability and actual use of bococizumab and an autoinjector (pre-filled pen).
Study identification
- NCT ID
- NCT02458287
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 299 participants
Conditions and interventions
Conditions
Interventions
- Bococizumab 150mg Biological
- Bococizumab 75mg Biological
- Bococizumab 150mg placebo Biological
- Bococizumab 75mg placebo Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2015 (Actual)
- Primary completion
- Feb 2016 (Actual)
- Completion
- Feb 2016 (Actual)
- Last update posted
- Dec 19, 2017
2015 – 2016
United States locations
- U.S. sites
- 30
- U.S. states
- 15
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Radiant Research Incorporated | Chandler | Arizona | 85224 | — |
| Clinical Trial Research | Lincoln | California | 95648 | — |
| National Research Institute | Los Angeles | California | 90057 | — |
| California Medical Research Associates Inc. | Northridge | California | 91324 | — |
| Northern California Research | Sacramento | California | 95821 | — |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | — |
| ACRC - Cardiology | Atlantis | Florida | 33462 | — |
| Clinical Research of South Florida | Coral Gables | Florida | 33134 | — |
| Invesclinic, LLC | Fort Lauderdale | Florida | 33308 | — |
| Clinical Research of Miami, Inc. | Miami | Florida | 33126 | — |
| Prestige Clinical Research Center, Inc. | Miami | Florida | 33133 | — |
| A & R Research Group LLC | Pembroke Pines | Florida | 33024 | — |
| Clinical Research Atlanta | Stockbridge | Georgia | 30281 | — |
| North Georgia Clinical Research | Woodstock | Georgia | 30189 | — |
| North Georgia Internal Medicine | Woodstock | Georgia | 30189 | — |
| Solaris Clinical Research | Meridian | Idaho | 83646 | — |
| Evanston Premier Healthcare Research,LLC | Evanston | Illinois | 60201 | — |
| Midwest Institute For Clinical Research | Indianapolis | Indiana | 46260 | — |
| Buynak Clinical Research, P.C. | Valparaiso | Indiana | 46383 | — |
| L-MARC Research Center | Louisville | Kentucky | 40213 | — |
| Omega Clinical Research Center | Metairie | Louisiana | 70006 | — |
| PharmQuest | Greensboro | North Carolina | 27408 | — |
| Sterling Research Group, Ltd. | Cincinnati | Ohio | 45219 | — |
| PMG Research Of Charleston | Mt. Pleasant | South Carolina | 29464 | — |
| Palmetto Clinical Research | Summerville | South Carolina | 29485 | — |
| Texas Center for Drug Development, Inc. | Houston | Texas | 77081 | — |
| Heart Care Associates, P.C. | Hopewell | Virginia | 23860 | — |
| Manassas Clinical Research Center | Manassas | Virginia | 20110 | — |
| National Clinical Research-Richmond, Inc. | Richmond | Virginia | 23294 | — |
| Rainier Clinical Research Center, Inc. | Renton | Washington | 98057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02458287, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2017 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02458287 live on ClinicalTrials.gov.